Belfast Telegraph

Home News Health

New drug liraglutide can reduce risk of developing diabetes

By John von Radowitz

An injected drug that reduces blood sugar and promotes weight loss can cut the chances of at-risk patients developing type 2 diabetes by 80%, research has shown.

The drug, liraglutide, interacts with brain regions that control appetite and energy intake.

A major international trial found that treatment with liraglutide had a dramatic effect on diabetes risk in obese and "pre-diabetes" patients en route to becoming chronically diabetic.

One in 10 of the UK population is thought to have pre-diabetes, a metabolic condition closely tied to obesity.

Study participants were randomly given either liraglutide or a placebo drug injected under the skin once a day for three years.

They were also placed on a reduced calorie diet and advised to take more exercise.

Compared with the placebo group, patients receiving the genuine treatment were 80% less likely to go on to develop type 2 diabetes.

Belfast Telegraph


From Belfast Telegraph